Max Wilberding
Impact in
-
- Pancreatic and Hepatic Oncology Research
- Peptidase Inhibition and Analysis
-
- Fibroblast Growth Factor Research
- Epigenetics and DNA Methylation
- Kruppel-like factors research
Papers in
- Surgery 4
- Enhanced Recovery After Surgery 2
- Cholangiocarcinoma and Gallbladder Cancer Studies 2
-
- Fibroblast Growth Factor Research 3
- Kruppel-like factors research 1
- Chromatin Remodeling and Cancer 1
- Co-authors
- Hui‐Zi Chen (3 shared papers)Julie W. Reeser (3 shared papers)Sameek Roychowdhury (3 shared papers)Melanie A. Krook (3 shared papers)Gary Li (1 shared paper)Gabrielle Ernst (1 shared paper)Amy Smith (1 shared paper)Kristen K. Ciombor (2 shared papers)
- Journals
- Journal of Surgical Research (2 papers)Molecular Cancer Therapeutics (1 paper)British Journal of Cancer (1 paper)Implementation Science Communications (1 paper)
- Partner nations
- United States
In The Last Decade
Max Wilberding
5 papers receiving 343 citations
Max Wilberding's Hit Papers
Peers
Comparison fields: 5 of 50
- Oncology 80
- Molecular Biology 218
- Cancer Research 43
- Surgery 122
- Rheumatology 36
Countries citing papers authored by Max Wilberding
This map shows the geographic impact of Max Wilberding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Wilberding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Wilberding more than expected).
Fields of papers citing papers by Max Wilberding
This network shows the impact of papers produced by Max Wilberding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Wilberding. The network helps show where Max Wilberding may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Wilberding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance Hit paper breakdown → | 2020 | 231 |
| 2 | 2020 | 110 | |
| 3 | 2023 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2019 | 1 | |
| 6 | 2025 | 0 |
About Max Wilberding
Max Wilberding is a scholar working on Surgery, Molecular Biology, General Health Professions, Pulmonary and Respiratory Medicine and Rheumatology, having authored 6 papers that have together received 347 indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (3 papers), Enhanced Recovery After Surgery (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Health Policy Implementation Science (1 paper), Kruppel-like factors research (1 paper), Chromatin Remodeling and Cancer (1 paper), Eosinophilic Disorders and Syndromes (1 paper) and Metastasis and carcinoma case studies (1 paper). The work is most often cited by research in Oncology (80 citations), Molecular Biology (218 citations), Cancer Research (43 citations), Surgery (122 citations) and Rheumatology (36 citations). Max Wilberding has collaborated with scholars based in United States. Frequent co-authors include Hui‐Zi Chen, Julie W. Reeser, Sameek Roychowdhury, Melanie A. Krook, Gary Li, Gabrielle Ernst, Amy Smith, Kristen K. Ciombor, Kelly M. Bailey and Eric Samorodnitsky. Their work appears in journals such as Journal of Surgical Research, Molecular Cancer Therapeutics, British Journal of Cancer and Implementation Science Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.